{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:58:58Z","timestamp":1793066338161,"version":"4.5.0"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s10787-025-01672-7","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:25:40Z","timestamp":1740443140000},"page":"1271-1287","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Ferroptosis role in complexity of cell death: unrevealing mechanisms in Parkinson\u2019s disease and therapeutic approaches"],"prefix":"10.1007","volume":"33","author":[{"given":"Anupam","family":"Awasthi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kousik","family":"Maparu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2780-6632","authenticated-orcid":false,"given":"Shamsher","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"key":"1672_CR1","unstructured":"Abbaspour N, Hurrell R, Kelishadi R (2014) Review on iron and its importance for human health. J Res Med Sci 19(2):164\u2013174. PMID: 24778671; PMCID: PMC3999603"},{"key":"1672_CR2","doi-asserted-by":"publisher","unstructured":"Alexander GE (2004) Biology of Parkinson\u2019s disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder. Dialogues Clin Neurosci 6(3):259\u2013280. https:\/\/doi.org\/10.31887\/DCNS.2004.6.3\/galexander","DOI":"10.31887\/DCNS.2004.6.3\/galexander"},{"issue":"4","key":"1672_CR3","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/jnc.13024","volume":"133","author":"PR Angelova","year":"2015","unstructured":"Angelova PR, Horrocks MH, Klenerman D, Gandhi S, Abramov AY, Shchepinov MS (2015) Lipid peroxidation is essential for \u03b1-synuclein-induced cell death. J Neurochem 133(4):582\u2013589. https:\/\/doi.org\/10.1111\/jnc.13024","journal-title":"J Neurochem"},{"issue":"3","key":"1672_CR4","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s11064-020-03186-w","volume":"46","author":"B Avc\u0131","year":"2021","unstructured":"Avc\u0131 B, G\u00fcnayd\u0131n C, G\u00fcven\u00e7 T, Yavuz CK, Kuruca N, Bilge SS (2021) Idebenone ameliorates rotenone-induced Parkinson\u2019s disease in rats through decreasing lipid peroxidation. Neurochem Res 46(3):513\u2013522. https:\/\/doi.org\/10.1007\/s11064-020-03186-w","journal-title":"Neurochem Res"},{"key":"1672_CR5","doi-asserted-by":"publisher","first-page":"16015","DOI":"10.1038\/sigtrans.2016.15","volume":"1","author":"S Ayton","year":"2016","unstructured":"Ayton S, Lei P, Mclean C, Bush AI, Finkelstein DI (2016) Transferrin protects against Parkinsonian neurotoxicity and is deficient in Parkinson\u2019s substantia nigra. Signal Transduct Target Ther 1:16015. https:\/\/doi.org\/10.1038\/sigtrans.2016.15","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"1672_CR6","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1089\/ars.2011.4429","volume":"18","author":"EJ Bae","year":"2013","unstructured":"Bae EJ, Ho DH, Park E, Jung JW, Cho K, Hong JH, Lee HJ, Kim KP, Lee SJ (2013) Lipid peroxidation product 4-hydroxy-2-nonenal promotes seeding-capable oligomer formation and cell-to-cell transfer of \u03b1-synuclein. Antioxid Redox Signal 18(7):770\u2013783. https:\/\/doi.org\/10.1089\/ars.2011.4429","journal-title":"Antioxid Redox Signal"},{"issue":"7","key":"1672_CR7","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1007\/s12035-021-02320-1","volume":"58","author":"L Bai","year":"2021","unstructured":"Bai L, Yan F, Deng R, Gu R, Zhang X, Bai J (2021) Thioredoxin-1 rescues MPP+\/MPTP-induced ferroptosis by increasing glutathione peroxidase 4. Mol Neurobiol 58(7):3187\u20133197. https:\/\/doi.org\/10.1007\/s12035-021-02320-1","journal-title":"Mol Neurobiol"},{"issue":"6","key":"1672_CR8","doi-asserted-by":"publisher","first-page":"3641","DOI":"10.1007\/s12035-023-03753-6","volume":"61","author":"Y Bao","year":"2024","unstructured":"Bao Y, Wang L, Liu H, Yang J, Yu F, Cui C, Huang D (2024) A diagnostic model for Parkinson\u2019s disease based on anoikis-related genes. Mol Neurobiol 61(6):3641\u20133656. https:\/\/doi.org\/10.1007\/s12035-023-03753-6","journal-title":"Mol Neurobiol"},{"key":"1672_CR9","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.atherosclerosis.2017.06.916","volume":"264","author":"JFP Berb\u00e9e","year":"2017","unstructured":"Berb\u00e9e JFP, Mol IM, Milne GL, Pollock E, Hoeke G, L\u00fctjohann D, Monaco C, Rensen PCN, van der Ploeg LHT, Shchepinov MS (2017) Deuterium-reinforced polyunsaturated fatty acids protect against atherosclerosis by lowering lipid peroxidation and hypercholesterolemia. Atherosclerosis 264:100\u2013107. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.06.916","journal-title":"Atherosclerosis"},{"issue":"7784","key":"1672_CR10","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker K, Hendricks JM, Li Z, Magtanong L, Ford B, Tang PH, Roberts MA, Tong B, Maimone TJ, Zoncu R, Bassik MC, Nomura DK, Dixon SJ, Olzmann JA (2019) The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature 575(7784):688\u2013692. https:\/\/doi.org\/10.1038\/s41586-019-1705-2","journal-title":"Nature"},{"issue":"2\u20133","key":"1672_CR11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s12017-017-8447-9","volume":"19","author":"E Carboni","year":"2017","unstructured":"Carboni E, Tatenhorst L, T\u00f6nges L, Barski E, Dambeck V, B\u00e4hr M, Lingor P (2017) Deferiprone rescues behavioral deficits induced by mild iron exposure in a mouse model of alpha-synuclein aggregation. Neuromolecular Med 19(2\u20133):309\u2013321. https:\/\/doi.org\/10.1007\/s12017-017-8447-9","journal-title":"Neuromolecular Med"},{"issue":"1","key":"1672_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13045-024-01564-3","volume":"17","author":"F Chen","year":"2024","unstructured":"Chen F, Kang R, Tang D, Liu J (2024) Ferroptosis: principles and significance in health and disease. J Hematol Oncol 17(1):41. https:\/\/doi.org\/10.1186\/s13045-024-01564-3","journal-title":"J Hematol Oncol"},{"issue":"8","key":"1672_CR13","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.3390\/antiox11081504","volume":"11","author":"H Chen","year":"2022","unstructured":"Chen H, Wang C, Liu Z, He X, Tang W, He L, Feng Y, Liu D, Yin Y, Li T (2022) Ferroptosis and its multifaceted role in cancer: mechanisms and therapeutic approach. Antioxidants 11(8):1504. https:\/\/doi.org\/10.3390\/antiox11081504","journal-title":"Antioxidants"},{"key":"1672_CR14","doi-asserted-by":"publisher","first-page":"107976","DOI":"10.1016\/j.neuropharm.2020.107976","volume":"167","author":"NM Chitre","year":"2020","unstructured":"Chitre NM, Wood BJ, Ray A, Moniri NH, Murnane KS (2020) Docosahexaenoic acid protects motor function and increases dopamine synthesis in a rat model of Parkinson\u2019s disease via mechanisms associated with increased protein kinase activity in the striatum. Neuropharmacology 167:107976. https:\/\/doi.org\/10.1016\/j.neuropharm.2020.107976","journal-title":"Neuropharmacology"},{"issue":"6","key":"1672_CR15","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1111\/j.1471-4159.2007.05097.x","volume":"104","author":"C Cleren","year":"2008","unstructured":"Cleren C, Yang L, Lorenzo B, Calingasan NY, Schomer A, Sireci A, Wille EJ, Beal MF (2008) Therapeutic effects of coenzyme Q10 (CoQ10) and reduced CoQ10 in the MPTP model of Parkinsonism. J Neurochem 104(6):1613\u20131621. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.05097.x","journal-title":"J Neurochem"},{"issue":"5","key":"1672_CR16","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.3390\/pharmaceutics15051369","volume":"15","author":"I Costa","year":"2023","unstructured":"Costa I, Barbosa DJ, Silva V, Benfeito S, Borges F, Remi\u00e3o F, Silva R (2023) Research models to study Ferroptosis\u2019s impact in neurodegenerative diseases. Pharmaceutics 15(5):1369. https:\/\/doi.org\/10.3390\/pharmaceutics15051369","journal-title":"Pharmaceutics"},{"key":"1672_CR17","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neulet.2016.02.011","volume":"617","author":"CC de Farias","year":"2016","unstructured":"de Farias CC, Maes M, Bonif\u00e1cio KL, Bortolasci CC, de Souza Nogueira A, Brinholi FF, Matsumoto AK, do Nascimento MA, de Melo LB, Nixdorf SL, Lavado EL, Moreira EG, Barbosa DS (2016) Highly specific changes in antioxidant levels and lipid peroxidation in Parkinson\u2019s disease and its progression: disease and staging biomarkers and new drug targets. Neurosci Lett 617:66\u201371. https:\/\/doi.org\/10.1016\/j.neulet.2016.02.011","journal-title":"Neurosci Lett"},{"issue":"8","key":"1672_CR18","first-page":"504","volume":"40","author":"G DeMaagd","year":"2015","unstructured":"DeMaagd G, Philip A (2015) Parkinson\u2019s disease and its management: part 1: disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis. P T 40(8):504\u2013532 (PMID: 26236139)","journal-title":"P T"},{"issue":"2","key":"1672_CR19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1089\/ars.2013.5593","volume":"21","author":"D Devos","year":"2014","unstructured":"Devos D, Moreau C, Devedjian JC, Kluza J, Petrault M, Laloux C, Jonneaux A, Ryckewaert G, Gar\u00e7on G, Rouaix N, Duhamel A, Jissendi P, Dujardin K, Auger F, Ravasi L, Hopes L, Grolez G, Firdaus W, Sablonni\u00e8re B, Strubi-Vuillaume I, Zahr N, Dest\u00e9e A, Corvol JC, P\u00f6ltl D, Leist M, Rose C, Defebvre L, Marchetti P, Cabantchik ZI, Bordet R (2014) Targeting chelatable iron as a therapeutic modality in Parkinson\u2019s disease. Antioxid Redox Signal 21(2):195\u2013210. https:\/\/doi.org\/10.1089\/ars.2013.5593","journal-title":"Antioxid Redox Signal"},{"issue":"8507","key":"1672_CR20","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/s0140-6736(86)92471-2","volume":"2","author":"D Dexter","year":"1986","unstructured":"Dexter D, Carter C, Agid F, Agid Y, Lees AJ, Jenner P, Marsden CD (1986) Lipid peroxidation as cause of nigral cell death in Parkinson\u2019s disease. Lancet 2(8507):639\u2013640. https:\/\/doi.org\/10.1016\/s0140-6736(86)92471-2","journal-title":"Lancet"},{"issue":"4","key":"1672_CR21","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3233\/JPD-130230","volume":"3","author":"V Dias","year":"2013","unstructured":"Dias V, Junn E, Mouradian MM (2013) The role of oxidative stress in Parkinson\u2019s disease. J Parkinsons Dis 3(4):461\u2013491. https:\/\/doi.org\/10.3233\/JPD-130230","journal-title":"J Parkinsons Dis"},{"issue":"5","key":"1672_CR22","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, Morrison B 3rd, Stockwell BR (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149(5):1060\u20131072. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042","journal-title":"Cell"},{"key":"1672_CR23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.nbd.2016.05.011","volume":"94","author":"B Van Do","year":"2016","unstructured":"Van Do B, Gouel F, Jonneaux A, Timmerman K, Gel\u00e9 P, P\u00e9trault M, Bastide M, Laloux C, Moreau C, Bordet R, Devos D, Devedjian JC (2016) Ferroptosis, a newly characterized form of cell death in Parkinson\u2019s disease that is regulated by PKC. Neurobiol Dis 94:169\u2013178. https:\/\/doi.org\/10.1016\/j.nbd.2016.05.011","journal-title":"Neurobiol Dis"},{"issue":"10","key":"1672_CR24","doi-asserted-by":"publisher","first-page":"7534","DOI":"10.1007\/s12035-024-04038-2","volume":"61","author":"Y Dong","year":"2024","unstructured":"Dong Y, Qi Y, Chen J, Han S, Su W, Ma X, Yu Y, Wang Y (2024) Neuroprotective effects of Bifidobacterium animalis subsp. lactis NJ241 in a mouse model of Parkinson\u2019s disease: implications for gut microbiota and PGC-1\u03b1. Mol Neurobiol 61(10):7534\u20137548. https:\/\/doi.org\/10.1007\/s12035-024-04038-2","journal-title":"Mol Neurobiol"},{"issue":"5","key":"1672_CR25","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","volume":"68","author":"ER Dorsey","year":"2007","unstructured":"Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, Tanner CM (2007) Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 68(5):384\u2013386. https:\/\/doi.org\/10.1212\/01.wnl.0000247740.47667.03","journal-title":"Neurology"},{"issue":"3","key":"1672_CR26","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s12264-012-1238-2","volume":"28","author":"XX Du","year":"2012","unstructured":"Du XX, Xu HM, Jiang H, Song N, Wang J, Xie JX (2012) Curcumin protects nigral dopaminergic neurons by iron-chelation in the 6-hydroxydopamine rat model of Parkinson\u2019s disease. Neurosci Bull 28(3):253\u2013258. https:\/\/doi.org\/10.1007\/s12264-012-1238-2","journal-title":"Neurosci Bull"},{"issue":"3","key":"1672_CR27","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3390\/antiox10030453","volume":"10","author":"AP Duarte-Jurado","year":"2021","unstructured":"Duarte-Jurado AP, Gopar-Cuevas Y, Saucedo-Cardenas O, Loera-Arias MJ, Montes-de-Oca-Luna R, Garcia-Garcia A, Rodriguez-Rocha H (2021) Antioxidant therapeutics in Parkinson\u2019s disease: current challenges and opportunities. Antioxidants 10(3):453. https:\/\/doi.org\/10.3390\/antiox10030453","journal-title":"Antioxidants"},{"issue":"9","key":"1672_CR28","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1002\/ajh.27010","volume":"98","author":"MS Elalfy","year":"2023","unstructured":"Elalfy MS, Hamdy M, Adly A, Ebeid FSE, Temin NT, Rozova A, Lee D, Fradette C, Tricta F (2023) Efficacy and safety of early-start deferiprone in infants and young children with transfusion-dependent beta-thalassemia: evidence for iron shuttling to transferrin in a randomized, double-blind, placebo-controlled, clinical trial (START). Am J Hematol 98(9):1415\u20131424. https:\/\/doi.org\/10.1002\/ajh.27010","journal-title":"Am J Hematol"},{"issue":"1","key":"1672_CR29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1152\/advan.00088.2006","volume":"31","author":"KM Eyster","year":"2007","unstructured":"Eyster KM (2007) The membrane and lipids as integral participants in signal transduction: lipid signal transduction for the non-lipid biochemist. Adv Physiol Educ 31(1):5\u201316. https:\/\/doi.org\/10.1152\/advan.00088.2006","journal-title":"Adv Physiol Educ"},{"issue":"5","key":"1672_CR30","doi-asserted-by":"publisher","first-page":"e2006203","DOI":"10.1371\/journal.pbio.2006203","volume":"16","author":"H Feng","year":"2018","unstructured":"Feng H, Stockwell BR (2018) Unsolved mysteries: how does lipid peroxidation cause ferroptosis? PLoS Biol 16(5):e2006203. https:\/\/doi.org\/10.1371\/journal.pbio.2006203","journal-title":"PLoS Biol"},{"issue":"1","key":"1672_CR31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s43556-023-00142-2","volume":"4","author":"S Feng","year":"2023","unstructured":"Feng S, Tang D, Wang Y, Li X, Bao H, Tang C, Dong X, Li X, Yang Q, Yan Y, Yin Z, Shang T, Zheng K, Huang X, Wei Z, Wang K, Qi S (2023) The mechanism of ferroptosis and its related diseases. Mol Biomed 4(1):33. https:\/\/doi.org\/10.1186\/s43556-023-00142-2","journal-title":"Mol Biomed"},{"key":"1672_CR32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40478-017-0456-2","volume":"5","author":"DI Finkelstein","year":"2017","unstructured":"Finkelstein DI, Billings JL, Adlard PA, Ayton S, Sedjahtera A, Masters CL, Wilkins S, Shackleford DM, Charman SA, Bal W, Zawisza IA, Kurowska E, Gundlach AL, Ma S, Bush AI, Hare DJ, Doble PA, Crawford S, Gautier EC, Parsons J, Huggins P, Barnham KJ, Cherny RA (2017) The novel compound PBT434 prevents iron-mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson\u2019s disease. Acta Neuropathol Commun 5:53. https:\/\/doi.org\/10.1186\/s40478-017-0456-2","journal-title":"Acta Neuropathol Commun"},{"issue":"11","key":"1672_CR33","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1111\/febs.14807","volume":"286","author":"AM Firsov","year":"2019","unstructured":"Firsov AM, Fomich MA, Bekish AV, Sharko OL, Kotova EA, Saal HJ, Vidovic D, Shmanai VV, Pratt DA, Antonenko YN, Shchepinov MS (2019) Threshold protective effect of deuterated polyunsaturated fatty acids on peroxidation of lipid bilayers. FEBS J 286(11):2099\u20132117. https:\/\/doi.org\/10.1111\/febs.14807","journal-title":"FEBS J"},{"issue":"2","key":"1672_CR34","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3390\/biomedicines9020109","volume":"9","author":"R Franco","year":"2021","unstructured":"Franco R, Reyes-Resina I, Navarro G (2021) Dopamine in health and disease: much more than a neurotransmitter. Biomedicines 9(2):109. https:\/\/doi.org\/10.3390\/biomedicines9020109","journal-title":"Biomedicines"},{"issue":"4","key":"1672_CR35","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.cell.2011.10.033","volume":"147","author":"Y Fuchs","year":"2011","unstructured":"Fuchs Y, Steller H (2011) Programmed cell death in animal development and disease. Cell 147(4):742\u2013758. https:\/\/doi.org\/10.1016\/j.cell.2011.10.033","journal-title":"Cell"},{"key":"1672_CR36","doi-asserted-by":"publisher","first-page":"102357","DOI":"10.1016\/j.arr.2024.102357","volume":"99","author":"DG Gadhave","year":"2024","unstructured":"Gadhave DG, Sugandhi VV, Jha SK, Nangare SN, Gupta G, Singh SK, Dua K, Cho H, Hansbro PM, Paudel KR (2024) Neurodegenerative disorders: mechanisms of degeneration and therapeutic approaches with their clinical relevance. Ageing Res Rev 99:102357. https:\/\/doi.org\/10.1016\/j.arr.2024.102357","journal-title":"Ageing Res Rev"},{"issue":"12","key":"1672_CR37","doi-asserted-by":"publisher","first-page":"118535","DOI":"10.1016\/j.bbamcr.2019.118535","volume":"1866","author":"D Galaris","year":"2019","unstructured":"Galaris D, Barbouti A, Pantopoulos K (2019) Iron homeostasis and oxidative stress: an intimate relationship. Biochim Biophys Acta Mol Cell Res 1866(12):118535. https:\/\/doi.org\/10.1016\/j.bbamcr.2019.118535","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"1672_CR38","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3389\/fphar.2020.00356","volume":"11","author":"M G\u00f3mez-Benito","year":"2020","unstructured":"G\u00f3mez-Benito M, Granado N, Garc\u00eda-Sanz P, Michel A, Dumoulin M, Moratalla R (2020) Modeling Parkinson\u2019s disease with the alpha-synuclein protein. Front Pharmacol 11:356. https:\/\/doi.org\/10.3389\/fphar.2020.00356","journal-title":"Front Pharmacol"},{"issue":"3","key":"1672_CR39","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3390\/brainsci13030508","volume":"13","author":"HA Gonz\u00e1lez-Usigli","year":"2023","unstructured":"Gonz\u00e1lez-Usigli HA, Ortiz GG, Charles-Ni\u00f1o C, Mireles-Ram\u00edrez MA, Pacheco-Mois\u00e9s FP, Torres-Mendoza BMG, Hern\u00e1ndez-Cruz JJ, Delgado-Lara DLDC, Ram\u00edrez-Jirano LJ (2023) Neurocognitive psychiatric and neuropsychological alterations in Parkinson\u2019s disease: a basic and clinical approach. Brain Sci 13(3):508. https:\/\/doi.org\/10.3390\/brainsci13030508","journal-title":"Brain Sci"},{"key":"1672_CR40","doi-asserted-by":"publisher","first-page":"120547","DOI":"10.1016\/j.neuroimage.2024.120547","volume":"289","author":"X Guan","year":"2024","unstructured":"Guan X, Lancione M, Ayton S, Dusek P, Langkammer C, Zhang M (2024) Neuroimaging of Parkinson\u2019s disease by quantitative susceptibility mapping. Neuroimage 289:120547. https:\/\/doi.org\/10.1016\/j.neuroimage.2024.120547","journal-title":"Neuroimage"},{"key":"1672_CR41","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.expneurol.2016.03.016","volume":"280","author":"C Guo","year":"2016","unstructured":"Guo C, Hao LJ, Yang ZH, Chai R, Zhang S, Gu Y, Gao HL, Zhong ML, Wang T, Li JY, Wang ZY (2016) Deferoxamine-mediated up-regulation of HIF-1\u03b1 prevents dopaminergic neuronal death via the activation of MAPK family proteins in MPTP-treated mice. Exp Neurol 280:13\u201323. https:\/\/doi.org\/10.1016\/j.expneurol.2016.03.016","journal-title":"Exp Neurol"},{"issue":"5","key":"1672_CR42","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s10787-010-0052-6","volume":"18","author":"A Gupta","year":"2010","unstructured":"Gupta A, Kumar A, Kulkarni SK (2010) Licofelone attenuates MPTP-induced neuronal toxicity: behavioral, biochemical and cellular evidence. Inflammopharmacology 18(5):223\u2013232. https:\/\/doi.org\/10.1007\/s10787-010-0052-6","journal-title":"Inflammopharmacology"},{"issue":"2","key":"1672_CR43","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/cdd.2015.93","volume":"23","author":"M Hayano","year":"2016","unstructured":"Hayano M, Yang WS, Corn CK, Pagano NC, Stockwell BR (2016) Loss of cysteinyl-tRNA synthetase (CARS) induces the transsulfuration pathway and inhibits ferroptosis induced by cystine deprivation. Cell Death Differ 23(2):270\u2013278. https:\/\/doi.org\/10.1038\/cdd.2015.93","journal-title":"Cell Death Differ"},{"key":"1672_CR44","doi-asserted-by":"publisher","first-page":"101928","DOI":"10.1016\/j.redox.2021.101928","volume":"42","author":"T Hong","year":"2021","unstructured":"Hong T, Lei G, Chen X, Li H, Zhang X, Wu N, Zhao Y, Zhang Y, Wang J (2021) PARP inhibition promotes ferroptosis via repressing SLC7A11 and synergizes with ferroptosis inducers in BRCA-proficient ovarian cancer. Redox Biol 42:101928. https:\/\/doi.org\/10.1016\/j.redox.2021.101928","journal-title":"Redox Biol"},{"issue":"13","key":"1672_CR45","doi-asserted-by":"publisher","first-page":"eadk1200","DOI":"10.1126\/sciadv.adk1200","volume":"10","author":"Q Huang","year":"2024","unstructured":"Huang Q, Ru Y, Luo Y, Luo X, Liu D, Ma Y, Zhou X, Linghu M, Xu W, Gao F, Huang Y (2024) Identification of a targeted ACSL4 inhibitor to treat ferroptosis-related diseases. Sci Adv 10(13):eadk1200. https:\/\/doi.org\/10.1126\/sciadv.adk1200","journal-title":"Sci Adv"},{"issue":"1","key":"1672_CR46","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1038\/s41598-018-21343-8","volume":"8","author":"KG Iliadi","year":"2018","unstructured":"Iliadi KG, Gluscencova OB, Iliadi N, Boulianne GL (2018) Mutations in the Drosophila homolog of human PLA2G6 give rise to age-dependent loss of psychomotor activity and neurodegeneration. Sci Rep 8(1):2939. https:\/\/doi.org\/10.1038\/s41598-018-21343-8","journal-title":"Sci Rep"},{"key":"1672_CR47","doi-asserted-by":"publisher","first-page":"117716","DOI":"10.1016\/j.bmc.2024.117716","volume":"105","author":"HL Ji","year":"2024","unstructured":"Ji HL, Zhang YF, Zhang NY, Wang KM, Meng N, Zhang J, Jiang CS (2024) Design, synthesis, and evaluation of formylpiperazine analogs of Ferrostatin-1 as novel improved ferroptosis inhibitors. Bioorg Med Chem 105:117716. https:\/\/doi.org\/10.1016\/j.bmc.2024.117716","journal-title":"Bioorg Med Chem"},{"issue":"4","key":"1672_CR48","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M (2021) Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol 22(4):266\u2013282. https:\/\/doi.org\/10.1038\/s41580-020-00324-8","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"1672_CR49","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/s0896-6273(03)00126-0","volume":"37","author":"D Kaur","year":"2003","unstructured":"Kaur D, Yantiri F, Rajagopalan S, Kumar J, Mo JQ, Boonplueang R, Viswanath V, Jacobs R, Yang L, Beal MF, DiMonte D, Volitaskis I, Ellerby L, Cherny RA, Bush AI, Andersen JK (2003) Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson\u2019s disease. Neuron 37(6):899\u2013909. https:\/\/doi.org\/10.1016\/s0896-6273(03)00126-0","journal-title":"Neuron"},{"issue":"Pt 7","key":"1672_CR50","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1093\/brain\/awv132","volume":"138","author":"KJ Kinghorn","year":"2015","unstructured":"Kinghorn KJ, Castillo-Quan JI, Bartolome F, Angelova PR, Li L, Pope S, Cochem\u00e9 HM, Khan S, Asghari S, Bhatia KP, Hardy J, Abramov AY, Partridge L (2015) Loss of PLA2G6 leads to elevated mitochondrial lipid peroxidation and mitochondrial dysfunction. Brain 138(Pt 7):1801\u20131816. https:\/\/doi.org\/10.1093\/brain\/awv132","journal-title":"Brain"},{"issue":"7","key":"1672_CR51","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S1474-4422(19)30142-5","volume":"18","author":"T Klopstock","year":"2019","unstructured":"Klopstock T, Tricta F, Neumayr L, Karin I, Zorzi G, Fradette C, Kmie\u0107 T, B\u00fcchner B, Steele HE, Horvath R, Chinnery PF, Basu A, K\u00fcpper C, Neuhofer C, K\u00e1lm\u00e1n B, Du\u0161ek P, Yapici Z, Wilson I, Zhao F, Zibordi F, Nardocci N, Aguilar C, Hayflick SJ, Spino M, Blamire AM, Hogarth P, Vichinsky E (2019) Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomized, double-blind, controlled trial and an open-label extension study. Lancet Neurol 18(7):631\u2013642. https:\/\/doi.org\/10.1016\/S1474-4422(19)30142-5","journal-title":"Lancet Neurol"},{"issue":"11","key":"1672_CR52","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.3390\/biomedicines9111679","volume":"9","author":"CJ Ko","year":"2021","unstructured":"Ko CJ, Gao SL, Lin TK, Chu PY, Lin HY (2021) Ferroptosis as a major factor and therapeutic target for neuroinflammation in Parkinson\u2019s disease. Biomedicines 9(11):1679. https:\/\/doi.org\/10.3390\/biomedicines9111679","journal-title":"Biomedicines"},{"key":"1672_CR53","doi-asserted-by":"publisher","unstructured":"Kouli A, Torsney KM, Kuan WL (2018) Parkinson\u2019s disease: etiology, neuropathology, and pathogenesis. In: Stoker TB, Greenland JC (eds) Parkinson\u2019s disease: pathogenesis and clinical aspects. Codon Publications, Brisbane. Chapter 1. PMID: 30702842. Bookshelf ID: NBK53672. https:\/\/doi.org\/10.15586\/codonpublications.parkinsonsdisease.2018.ch1","DOI":"10.15586\/codonpublications.parkinsonsdisease.2018.ch1"},{"issue":"5","key":"1672_CR54","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1469-8749.2011.03955.x","volume":"53","author":"MA Kurian","year":"2011","unstructured":"Kurian MA, McNeill A, Lin JP, Maher ER (2011) Childhood disorders of neurodegeneration with brain iron accumulation (NBIA). Dev Med Child Neurol 53(5):394\u2013404. https:\/\/doi.org\/10.1111\/j.1469-8749.2011.03955.x","journal-title":"Dev Med Child Neurol"},{"issue":"9","key":"1672_CR55","doi-asserted-by":"publisher","first-page":"e0162460","DOI":"10.1371\/journal.pone.0162460","volume":"11","author":"C Langkammer","year":"2016","unstructured":"Langkammer C, Pirpamer L, Seiler S, Deistung A, Schweser F, Franthal S, Homayoon N, Katschnig-Winter P, Koegl-Wallner M, Pendl T, Stoegerer EM, Wenzel K, Fazekas F, Ropele S, Reichenbach JR, Schmidt R, Schwingenschuh P (2016) Quantitative susceptibility mapping in Parkinson\u2019s disease. PLoS ONE 11(9):e0162460. https:\/\/doi.org\/10.1371\/journal.pone.0162460","journal-title":"PLoS ONE"},{"issue":"51","key":"1672_CR56","doi-asserted-by":"publisher","first-page":"32433","DOI":"10.1073\/pnas.2006828117","volume":"117","author":"JY Lee","year":"2020","unstructured":"Lee JY, Nam M, Son HY, Hyun K, Jang SY, Kim JW, Kim MW, Jung Y, Jang E, Yoon SJ, Kim J, Kim J, Seo J, Min JK, Oh KJ, Han BS, Kim WK, Bae KH, Song J, Kim J, Huh YM, Hwang GS, Lee EW, Lee SC (2020) Polyunsaturated fatty acid biosynthesis pathway determines ferroptosis sensitivity in gastric cancer. Proc Natl Acad Sci U S A 117(51):32433\u201332442. https:\/\/doi.org\/10.1073\/pnas.2006828117","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1672_CR57","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3892\/ijmm.2021.4894","volume":"47","author":"X Li","year":"2021","unstructured":"Li X, Si W, Li Z, Tian Y, Liu X, Ye S, Huang Z, Ji Y, Zhao C, Hao X, Chen D, Zhu M (2021) miR-335 promotes ferroptosis by targeting ferritin heavy chain 1 in in vivo and in vitro models of Parkinson\u2019s disease. Int J Mol Med 47(4):61. https:\/\/doi.org\/10.3892\/ijmm.2021.4894","journal-title":"Int J Mol Med"},{"issue":"12","key":"1672_CR58","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/j.molcel.2022.03.022","volume":"82","author":"D Liang","year":"2022","unstructured":"Liang D, Minikes AM, Jiang X (2022) Ferroptosis at the intersection of lipid metabolism and cellular signaling. Mol Cell 82(12):2215\u20132227. https:\/\/doi.org\/10.1016\/j.molcel.2022.03.022","journal-title":"Mol Cell"},{"issue":"1","key":"1672_CR59","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s11658-023-00516-y","volume":"29","author":"J Liang","year":"2024","unstructured":"Liang J, Wan Z, Qian C, Rasheed M, Cao C, Sun J, Wang X, Chen Z, Deng Y (2024) The pyroptosis mediated biomarker pattern: an emerging diagnostic approach for Parkinson\u2019s disease. Cell Mol Biol Lett 29(1):7. https:\/\/doi.org\/10.1186\/s11658-023-00516-y","journal-title":"Cell Mol Biol Lett"},{"issue":"8","key":"1672_CR60","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1248\/bpb.b15-00048","volume":"38","author":"Y Liu","year":"2015","unstructured":"Liu Y, Wang W, Li Y, Xiao Y, Cheng J, Jia J (2015) The 5-lipoxygenase inhibitor zileuton confers neuroprotection against glutamate oxidative damage by inhibiting ferroptosis. Biol Pharm Bull 38(8):1234\u20131239. https:\/\/doi.org\/10.1248\/bpb.b15-00048","journal-title":"Biol Pharm Bull"},{"issue":"4","key":"1672_CR61","doi-asserted-by":"publisher","first-page":"e298","DOI":"10.1002\/mco2.298","volume":"4","author":"H Long","year":"2023","unstructured":"Long H, Zhu W, Wei L, Zhao J (2023) Iron homeostasis imbalance and ferroptosis in brain diseases. MedComm 4(4):e298. https:\/\/doi.org\/10.1002\/mco2.298","journal-title":"MedComm"},{"key":"1672_CR62","doi-asserted-by":"publisher","first-page":"1435139","DOI":"10.3389\/fimmu.2024.1435139","volume":"15","author":"Z Long","year":"2024","unstructured":"Long Z, Luo Y, Yu M, Wang X, Zeng L, Yang K (2024) Targeting ferroptosis: a new therapeutic opportunity for kidney diseases. Front Immunol 15:1435139. https:\/\/doi.org\/10.3389\/fimmu.2024.1435139","journal-title":"Front Immunol"},{"issue":"4","key":"1672_CR63","doi-asserted-by":"publisher","first-page":"a009357","DOI":"10.1101\/cshperspect.a009357","volume":"2","author":"MA Lynch-Day","year":"2012","unstructured":"Lynch-Day MA, Mao K, Wang K, Zhao M, Klionsky DJ (2012) The role of autophagy in Parkinson\u2019s disease. Cold Spring Harb Perspect Med 2(4):a009357. https:\/\/doi.org\/10.1101\/cshperspect.a009357","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1672_CR64","doi-asserted-by":"publisher","first-page":"101896","DOI":"10.1016\/j.redox.2021.101896","volume":"41","author":"L Ma","year":"2021","unstructured":"Ma L, Gholam Azad M, Dharmasivam M, Richardson V, Quinn RJ, Feng Y, Pountney DL, Tonissen KF, Mellick GD, Yanatori I, Richardson DR (2021) Parkinson\u2019s disease: alterations in iron and redox biology as a key to unlock therapeutic strategies. Redox Biol 41:101896. https:\/\/doi.org\/10.1016\/j.redox.2021.101896","journal-title":"Redox Biol"},{"issue":"6","key":"1672_CR65","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1089\/ars.2007.1893","volume":"10","author":"EL MacKenzie","year":"2008","unstructured":"MacKenzie EL, Iwasaki K, Tsuji Y (2008) Intracellular iron transport and storage: from molecular mechanisms to health implications. Antioxid Redox Signal 10(6):997\u20131030. https:\/\/doi.org\/10.1089\/ars.2007.1893","journal-title":"Antioxid Redox Signal"},{"key":"1672_CR66","doi-asserted-by":"publisher","first-page":"9832839","DOI":"10.1155\/2016\/9832839","volume":"2016","author":"F Magrinelli","year":"2016","unstructured":"Magrinelli F, Picelli A, Tocco P, Federico A, Roncari L, Smania N, Zanette G, Tamburin S (2016) Pathophysiology of motor dysfunction in Parkinson\u2019s disease as the rationale for drug treatment and rehabilitation. Parkinsons Dis 2016:9832839. https:\/\/doi.org\/10.1155\/2016\/9832839","journal-title":"Parkinsons Dis"},{"issue":"8","key":"1672_CR67","doi-asserted-by":"publisher","first-page":"111231","DOI":"10.1016\/j.celrep.2022.111231","volume":"40","author":"L Mahoney-Sanchez","year":"2022","unstructured":"Mahoney-Sanchez L, Bouchaoui H, Boussaad I, Jonneaux A, Timmerman K, Berdeaux O, Ayton S, Kr\u00fcger R, Duce JA, Devos D, Devedjian JC (2022) Alpha-synuclein determines ferroptosis sensitivity in dopaminergic neurons via modulation of ether-phospholipid membrane composition. Cell Rep 40(8):111231. https:\/\/doi.org\/10.1016\/j.celrep.2022.111231","journal-title":"Cell Rep"},{"issue":"15","key":"1672_CR68","doi-asserted-by":"publisher","first-page":"987","DOI":"10.2174\/0113894501312703240826070530","volume":"25","author":"M Majumdar","year":"2024","unstructured":"Majumdar M, Badwaik H (2024) Trends on novel targets and nanotechnology-based drug delivery system in the treatment of Parkinson\u2019s disease: recent advancement in drug development. Curr Drug Targets 25(15):987\u20131011. https:\/\/doi.org\/10.2174\/0113894501312703240826070530","journal-title":"Curr Drug Targets"},{"issue":"1","key":"1672_CR69","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1038\/s41598-017-01402-2","volume":"7","author":"A Martin-Bastida","year":"2017","unstructured":"Martin-Bastida A, Ward RJ, Newbould R, Piccini P, Sharp D, Kabba C, Patel MC, Spino M, Connelly J, Tricta F, Crichton RR, Dexter DT (2017) Brain iron chelation by deferiprone in phase 2 randomized double-blinded placebo-controlled clinical trial in Parkinson\u2019s disease. Sci Rep 7(1):1398. https:\/\/doi.org\/10.1038\/s41598-017-01402-2","journal-title":"Sci Rep"},{"issue":"2","key":"1672_CR70","doi-asserted-by":"publisher","first-page":"e14607","DOI":"10.1111\/cns.14607","volume":"30","author":"A Negida","year":"2024","unstructured":"Negida A, Hassan NM, Aboeldahab H, Zain YE, Negida Y, Cadri S, Cadri N, Cloud LJ, Barrett MJ, Berman B (2024) Efficacy of the iron-chelating agent, deferiprone, in patients with Parkinson\u2019s disease: a systematic review and meta-analysis. CNS Neurosci Ther 30(2):e14607. https:\/\/doi.org\/10.1111\/cns.14607","journal-title":"CNS Neurosci Ther"},{"issue":"14","key":"1672_CR71","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1056\/NEJM2003ra020003","volume":"348","author":"RL Nussbaum","year":"2003","unstructured":"Nussbaum RL, Ellis CE (2003) Alzheimer\u2019s disease and Parkinson\u2019s disease. N Engl J Med 348(14):1356\u20131364. https:\/\/doi.org\/10.1056\/NEJM2003ra020003","journal-title":"N Engl J Med"},{"issue":"9","key":"1672_CR72","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1002\/mds.27115","volume":"32","author":"JA Obeso","year":"2017","unstructured":"Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, Burn D, Halliday GM, Bezard E, Przedborski S, Lehericy S, Brooks DJ, Rothwell JC, Hallett M, DeLong MR, Marras C, Tanner CM, Ross GW, Langston JW, Klein C, Bonifati V, Jankovic J, Lozano AM, Deuschl G, Bergman H, Tolosa E, Rodriguez-Violante M, Fahn S, Postuma RB, Berg D, Marek K, Standaert DG, Surmeier DJ, Olanow CW, Kordower JH, Calabresi P, Schapira AHV, Stoessl AJ (2017) Past, present, and future of Parkinson\u2019s disease: a special essay on the 200th Anniversary of the Shaking Palsy. Mov Disord 32(9):1264\u20131310. https:\/\/doi.org\/10.1002\/mds.27115","journal-title":"Mov Disord"},{"issue":"9","key":"1672_CR73","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1038\/s12276-023-01107-9.Erratumfor:ExpMolMed.2023;55(8):1573-1594.10.1038\/s12276-023-01078-x","volume":"55","author":"W Park","year":"2023","unstructured":"Park W, Wei S, Kim BS, Kim B, Bae SJ, Chae YC, Ryu D, Ha KT (2023) Author correction: diversity and complexity of cell death: a historical review. Exp Mol Med 55(9):2083. https:\/\/doi.org\/10.1038\/s12276-023-01107-9.Erratumfor:ExpMolMed.2023;55(8):1573-1594.10.1038\/s12276-023-01078-x","journal-title":"Exp Mol Med"},{"key":"1672_CR74","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.parkreldis.2018.02.036","volume":"51","author":"S Pelucchi","year":"2018","unstructured":"Pelucchi S, Mariani R, Ravasi G, Pelloni I, Marano M, Tremolizzo L, Alessio M, Piperno A (2018) Phenotypic heterogeneity in seven Italian cases of aceruloplasminemia. Parkinsonism Relat Disord 51:36\u201342. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.02.036","journal-title":"Parkinsonism Relat Disord"},{"key":"1672_CR75","doi-asserted-by":"publisher","first-page":"108085","DOI":"10.1016\/j.neuropharm.2020.108085","volume":"171","author":"W Poewe","year":"2020","unstructured":"Poewe W, Seppi K, Marini K, Mahlknecht P (2020) New hopes for disease modification in Parkinson\u2019s disease. Neuropharmacology 171:108085. https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108085","journal-title":"Neuropharmacology"},{"issue":"3","key":"1672_CR76","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3390\/antiox13030298","volume":"13","author":"C Punziano","year":"2024","unstructured":"Punziano C, Trombetti S, Cesaro E, Grosso M, Faraonio R (2024) Antioxidant systems as modulators of ferroptosis: focus on transcription factors. Antioxidants 13(3):298. https:\/\/doi.org\/10.3390\/antiox13030298","journal-title":"Antioxidants"},{"issue":"3","key":"1672_CR77","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3934\/Neuroscience.2023017","volume":"10","author":"S Ramesh","year":"2023","unstructured":"Ramesh S, Arachchige ASPM (2023) Depletion of dopamine in Parkinson\u2019s disease and relevant therapeutic options: a review of the literature. AIMS Neurosci 10(3):200\u2013231. https:\/\/doi.org\/10.3934\/Neuroscience.2023017","journal-title":"AIMS Neurosci"},{"issue":"6","key":"1672_CR78","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/ejn.16136","volume":"59","author":"M Regoni","year":"2024","unstructured":"Regoni M, Valtorta F, Sassone J (2024) Dopaminergic neuronal death via necroptosis in Parkinson\u2019s disease: a review of the literature. Eur J Neurosci 59(6):1079\u20131098. https:\/\/doi.org\/10.1111\/ejn.16136","journal-title":"Eur J Neurosci"},{"issue":"22","key":"1672_CR79","doi-asserted-by":"publisher","first-page":"8765","DOI":"10.3390\/ijms21228765","volume":"21","author":"CO Reichert","year":"2020","unstructured":"Reichert CO, de Freitas FA, Sampaio-Silva J, Rokita-Rosa L, Barros PL, Levy D, Bydlowski SP (2020) Ferroptosis mechanisms involved in neurodegenerative diseases. Int J Mol Sci 21(22):8765. https:\/\/doi.org\/10.3390\/ijms21228765","journal-title":"Int J Mol Sci"},{"issue":"47","key":"1672_CR80","doi-asserted-by":"publisher","first-page":"18578","DOI":"10.1073\/pnas.0804373105","volume":"105","author":"J Salazar","year":"2008","unstructured":"Salazar J, Mena N, Hunot S, Prigent A, Alvarez-Fischer D, Arredondo M, Duyckaerts C, Sazdovitch V, Zhao L, Garrick LM, Nu\u00f1ez MT, Garrick MD, Raisman-Vozari R, Hirsch EC (2008) Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson\u2019s disease. Proc Natl Acad Sci U S A 105(47):18578\u201318583. https:\/\/doi.org\/10.1073\/pnas.0804373105","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1672_CR81","doi-asserted-by":"publisher","first-page":"986","DOI":"10.3390\/nu13030986","volume":"13","author":"V Sambra","year":"2021","unstructured":"Sambra V, Echeverria F, Valenzuela A, Chouinard-Watkins R, Valenzuela R (2021) Docosahexaenoic and arachidonic acids as neuroprotective nutrients throughout the life cycle. Nutrients 13(3):986. https:\/\/doi.org\/10.3390\/nu13030986","journal-title":"Nutrients"},{"key":"1672_CR82","doi-asserted-by":"publisher","first-page":"e73456","DOI":"10.7554\/eLife.73456","volume":"11","author":"T Sato","year":"2022","unstructured":"Sato T, Shapiro JS, Chang HC, Miller RA, Ardehali H (2022) Aging is associated with increased brain iron through cortex-derived hepcidin expression. Elife 11:e73456. https:\/\/doi.org\/10.7554\/eLife.73456","journal-title":"Elife"},{"key":"1672_CR83","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/7854_2014_317","volume":"22","author":"SA Schneider","year":"2015","unstructured":"Schneider SA, Obeso JA (2015) Clinical and pathological features of Parkinson\u2019s disease. Curr Top Behav Neurosci 22:205\u2013220. https:\/\/doi.org\/10.1007\/7854_2014_317","journal-title":"Curr Top Behav Neurosci"},{"issue":"10","key":"1672_CR84","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/ejhg.2014.300","volume":"23","author":"EC Schulte","year":"2015","unstructured":"Schulte EC, Fukumori A, Mollenhauer B, Hor H, Arzberger T, Perneczky R, Kurz A, Diehl-Schmid J, H\u00fcll M, Lichtner P, Eckstein G, Zimprich A, Haubenberger D, Pirker W, Br\u00fccke T, Bereznai B, Molnar MJ, Lorenzo-Betancor O, Pastor P, Peters A, Gieger C, Estivill X, Meitinger T, Kretzschmar HA, Trenkwalder C, Haass C, Winkelmann J (2015) Rare variants in \u03b2-Amyloid precursor protein (APP) and Parkinson\u2019s disease. Eur J Hum Genet 23(10):1328\u20131333. https:\/\/doi.org\/10.1038\/ejhg.2014.300","journal-title":"Eur J Hum Genet"},{"issue":"7","key":"1672_CR85","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/s0278-5846(96)00103-0","volume":"20","author":"G Sechi","year":"1996","unstructured":"Sechi G, Deledda MG, Bua G, Satta WM, Deiana GA, Pes GM, Rosati G (1996) Reduced intravenous glutathione in the treatment of early Parkinson\u2019s disease. Prog Neuropsychopharmacol Biol Psychiatry 20(7):1159\u20131170. https:\/\/doi.org\/10.1016\/s0278-5846(96)00103-0","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"1672_CR86","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.neuropharm.2003.09.005","volume":"46","author":"DB Shachar","year":"2004","unstructured":"Shachar DB, Kahana N, Kampel V, Warshawsky A, Youdim MB (2004) Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats. Neuropharmacology 46(2):254\u2013263. https:\/\/doi.org\/10.1016\/j.neuropharm.2003.09.005","journal-title":"Neuropharmacology"},{"issue":"2","key":"1672_CR87","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.toxlet.2011.07.020","volume":"207","author":"MS Shchepinov","year":"2011","unstructured":"Shchepinov MS, Chou VP, Pollock E, Langston JW, Cantor CR, Molinari RJ, Manning-Bo\u011f AB (2011) Isotopic reinforcement of essential polyunsaturated fatty acids diminishes nigrostriatal degeneration in a mouse model of Parkinson\u2019s disease. Toxicol Lett 207(2):97\u2013103. https:\/\/doi.org\/10.1016\/j.toxlet.2011.07.020","journal-title":"Toxicol Lett"},{"key":"1672_CR88","doi-asserted-by":"publisher","unstructured":"Shi L, Huang C, Luo Q, Xia Y, Liu W, Zeng W, Cheng A, Shi R, Zhengli C (2020) Clioquinol improves motor and non-motor deficits in MPTP-induced monkey model of Parkinson\u2019s disease through AKT\/mTOR pathway. Aging 12(10):9515\u20139533. https:\/\/doi.org\/10.18632\/aging.103225","DOI":"10.18632\/aging.103225"},{"issue":"6","key":"1672_CR89","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1111\/j.1471-4159.2010.07132.x","volume":"118","author":"J Sian-H\u00fclsmann","year":"2011","unstructured":"Sian-H\u00fclsmann J, Mandel S, Youdim MB, Riederer P (2011) The relevance of iron in the pathogenesis of Parkinson\u2019s disease. J Neurochem 118(6):939\u2013957. https:\/\/doi.org\/10.1111\/j.1471-4159.2010.07132.x","journal-title":"J Neurochem"},{"issue":"12","key":"1672_CR90","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.1021\/ja411006a","volume":"136","author":"R Skouta","year":"2014","unstructured":"Skouta R, Dixon SJ, Wang J, Dunn DE, Orman M, Shimada K, Rosenberg PA, Lo DC, Weinberg JM, Linkermann A, Stockwell BR (2014) Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models. J Am Chem Soc 136(12):4551\u20134556. https:\/\/doi.org\/10.1021\/ja411006a","journal-title":"J Am Chem Soc"},{"issue":"3","key":"1672_CR91","doi-asserted-by":"publisher","first-page":"100091","DOI":"10.1016\/j.cellin.2023.100091","volume":"2","author":"J Snyder","year":"2023","unstructured":"Snyder J, Wu Z (2023) Origins of nervous tissue susceptibility to ferroptosis. Cell Insight 2(3):100091. https:\/\/doi.org\/10.1016\/j.cellin.2023.100091","journal-title":"Cell Insight"},{"issue":"5","key":"1672_CR92","doi-asserted-by":"publisher","first-page":"102431","DOI":"10.1016\/j.isci.2021.102431","volume":"24","author":"LM Song","year":"2021","unstructured":"Song LM, Xiao ZX, Zhang N, Yu XQ, Cui W, Xie JX, Xu HM (2021) Apoferritin improves motor deficits in MPTP-treated mice by regulating brain iron metabolism and ferroptosis. iScience 24(5):102431. https:\/\/doi.org\/10.1016\/j.isci.2021.102431","journal-title":"iScience"},{"key":"1672_CR93","doi-asserted-by":"publisher","first-page":"1390798","DOI":"10.3389\/fphar.2024.1390798","volume":"15","author":"P Soni","year":"2024","unstructured":"Soni P, Ammal Kaidery N, Sharma SM, Gazaryan I, Nikulin SV, Hushpulian DM, Thomas B (2024) A critical appraisal of ferroptosis in Alzheimer\u2019s and Parkinson\u2019s disease: new insights into emerging mechanisms and therapeutic targets. Front Pharmacol 15:1390798. https:\/\/doi.org\/10.3389\/fphar.2024.1390798","journal-title":"Front Pharmacol"},{"issue":"Pt 1","key":"1672_CR94","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1093\/brain\/awh322","volume":"128","author":"K Stiasny-Kolster","year":"2005","unstructured":"Stiasny-Kolster K, Doerr Y, M\u00f6ller JC, H\u00f6ffken H, Behr TM, Oertel WH, Mayer G (2005) Combination of \u2018idiopathic\u2019 REM sleep behavior disorder and olfactory dysfunction as a possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain 128(Pt 1):126\u2013137. https:\/\/doi.org\/10.1093\/brain\/awh322","journal-title":"Brain"},{"issue":"2","key":"1672_CR95","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, Fulda S, Gasc\u00f3n S, Hatzios SK, Kagan VE, Noel K, Jiang X, Linkermann A, Murphy ME, Overholtzer M, Oyagi A, Pagnussat GC, Park J, Ran Q, Rosenfeld CS, Salnikow K, Tang D, Torti FM, Torti SV, Toyokuni S, Woerpel KA, Zhang DD (2017) Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell 171(2):273\u2013285. https:\/\/doi.org\/10.1016\/j.cell.2017.09.021","journal-title":"Cell"},{"key":"1672_CR96","doi-asserted-by":"publisher","first-page":"110991","DOI":"10.1016\/j.brainresbull.2024.110991","volume":"213","author":"Y Su","year":"2024","unstructured":"Su Y, Jiao Y, Cai S, Xu Y, Wang Q, Chen X (2024) The molecular mechanism of ferroptosis and its relationship with Parkinson\u2019s disease. Brain Res Bull 213:110991. https:\/\/doi.org\/10.1016\/j.brainresbull.2024.110991","journal-title":"Brain Res Bull"},{"issue":"2","key":"1672_CR97","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3390\/antiox10020236","volume":"10","author":"JM Su\u00e1rez-Rivero","year":"2021","unstructured":"Su\u00e1rez-Rivero JM, Pastor-Maldonado CJ, Povea-Cabello S, \u00c1lvarez-C\u00f3rdoba M, Villal\u00f3n-Garc\u00eda I, Munuera-Cabeza M, Su\u00e1rez-Carrillo A, Talaver\u00f3n-Rey M, S\u00e1nchez-Alc\u00e1zar JA (2021) Coenzyme Q10 analogues: benefits and challenges for therapeutics. Antioxidants 10(2):236. https:\/\/doi.org\/10.3390\/antiox10020236","journal-title":"Antioxidants"},{"issue":"1","key":"1672_CR98","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41392-023-01606-1","volume":"8","author":"S Sun","year":"2023","unstructured":"Sun S, Shen J, Jiang J, Wang F, Min J (2023) Targeting ferroptosis opens new avenues for the development of novel therapeutics. Signal Transduct Target Ther 8(1):372. https:\/\/doi.org\/10.1038\/s41392-023-01606-1","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"1672_CR99","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang D, Chen X, Kang R, Kroemer G (2021) Ferroptosis: molecular mechanisms and health implications. Cell Res 31(2):107\u2013125. https:\/\/doi.org\/10.1038\/s41422-020-00441-1","journal-title":"Cell Res"},{"issue":"12","key":"1672_CR100","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.3390\/molecules23123305","volume":"23","author":"G Tardiolo","year":"2018","unstructured":"Tardiolo G, Bramanti P, Mazzon E (2018) Overview on the effects of N-acetylcysteine in neurodegenerative diseases. Molecules 23(12):3305. https:\/\/doi.org\/10.3390\/molecules23123305","journal-title":"Molecules"},{"key":"1672_CR101","doi-asserted-by":"publisher","unstructured":"Tolosa E, Mart\u00ed MJ, Valldeoriola F, Molinuevo JL (1998) History of levodopa and dopamine agonists in Parkinson\u2019s disease treatment. Neurology 50(6 Suppl 6):S2\u201310; discussion S44\u20138. https:\/\/doi.org\/10.1212\/wnl.50.6_suppl_6.s2","DOI":"10.1212\/wnl.50.6_suppl_6.s2"},{"issue":"9","key":"1672_CR102","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.3390\/biom13091291","volume":"13","author":"L Valgimigli","year":"2023","unstructured":"Valgimigli L (2023) Lipid peroxidation and antioxidant protection. Biomolecules 13(9):1291. https:\/\/doi.org\/10.3390\/biom13091291","journal-title":"Biomolecules"},{"key":"1672_CR103","doi-asserted-by":"publisher","first-page":"1309635","DOI":"10.3389\/fimmu.2023.1309635","volume":"14","author":"M Wang","year":"2024","unstructured":"Wang M, Yu F, Zhang Y, Li P (2024) Programmed cell death in tumor immunity: mechanistic insights and clinical implications. Front Immunol 14:1309635. https:\/\/doi.org\/10.3389\/fimmu.2023.1309635","journal-title":"Front Immunol"},{"issue":"4","key":"1672_CR104","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.molmed.2022.02.003","volume":"28","author":"ZL Wang","year":"2022","unstructured":"Wang ZL, Yuan L, Li W, Li JY (2022) Ferroptosis in Parkinson\u2019s disease: glia-neuron crosstalk. Trends Mol Med 28(4):258\u2013269. https:\/\/doi.org\/10.1016\/j.molmed.2022.02.003","journal-title":"Trends Mol Med"},{"issue":"10","key":"1672_CR105","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S1474-4422(14)70117-6","volume":"13","author":"RJ Ward","year":"2014","unstructured":"Ward RJ, Zucca FA, Duyn JH, Crichton RR, Zecca L (2014) The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol 13(10):1045\u20131060. https:\/\/doi.org\/10.1016\/S1474-4422(14)70117-6","journal-title":"Lancet Neurol"},{"key":"1672_CR106","doi-asserted-by":"publisher","first-page":"111065","DOI":"10.1016\/j.brainresbull.2024.111065","volume":"217","author":"C Wei","year":"2024","unstructured":"Wei C (2024) The role of glutathione peroxidase 4 in neuronal ferroptosis and its therapeutic potential in ischemic and hemorrhagic stroke. Brain Res Bull 217:111065. https:\/\/doi.org\/10.1016\/j.brainresbull.2024.111065","journal-title":"Brain Res Bull"},{"issue":"6","key":"1672_CR107","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.3390\/nu12061784","volume":"12","author":"M Wici\u0144ski","year":"2020","unstructured":"Wici\u0144ski M, Liczner G, Cadelski K, Ko\u0142nierzak T, Nowaczewska M, Malinowski B (2020) Anemia of chronic diseases: wider diagnostics-better treatment? Nutrients 12(6):1784. https:\/\/doi.org\/10.3390\/nu12061784","journal-title":"Nutrients"},{"issue":"1","key":"1672_CR108","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41392-020-00428-9","volume":"6","author":"HF Yan","year":"2021","unstructured":"Yan HF, Zou T, Tuo QZ, Xu S, Li H, Belaidi AA, Lei P (2021) Ferroptosis: mechanisms and links with diseases. Signal Transduct Target Ther 6(1):49. https:\/\/doi.org\/10.1038\/s41392-020-00428-9","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"1672_CR109","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41420-022-00826-8","volume":"8","author":"J Yan","year":"2022","unstructured":"Yan J, Sun W, Shen M, Zhang Y, Jiang M, Liu A, Ma H, Lai X, Wu J (2022) Idebenone improves motor dysfunction, learning and memory by regulating mitophagy in MPTP-treated mice. Cell Death Discov 8(1):28. https:\/\/doi.org\/10.1038\/s41420-022-00826-8","journal-title":"Cell Death Discov"},{"key":"1672_CR110","doi-asserted-by":"publisher","first-page":"116174","DOI":"10.1016\/j.bcp.2024.116174","volume":"228","author":"L Yang","year":"2024","unstructured":"Yang L, Guttman L, Dawson VL, Dawson TM (2024) Parthanatos: mechanisms, modulation, and therapeutic prospects in neurodegenerative disease and stroke. Biochem Pharmacol 228:116174. https:\/\/doi.org\/10.1016\/j.bcp.2024.116174","journal-title":"Biochem Pharmacol"},{"issue":"34","key":"1672_CR111","doi-asserted-by":"publisher","first-page":"E4966","DOI":"10.1073\/pnas.1603244113","volume":"113","author":"WS Yang","year":"2016","unstructured":"Yang WS, Kim KJ, Gaschler MM, Patel M, Shchepinov MS, Stockwell BR (2016) Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci U S A 113(34):E4966\u2013E4975. https:\/\/doi.org\/10.1073\/pnas.1603244113","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1672_CR112","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4236\/cellbio.2013.22005","volume":"2","author":"MMAR Yazdanparast","year":"2013","unstructured":"Yazdanparast MMAR (2013) Protective effects of flavonoid baicalein against menadione-induced damage in SK-N-MC cells. Cell Bio 2:35\u201344. https:\/\/doi.org\/10.4236\/cellbio.2013.22005","journal-title":"Cell Bio"},{"issue":"18","key":"1672_CR113","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1016\/j.molcel.2021.08.027","volume":"81","author":"H Yoon","year":"2021","unstructured":"Yoon H, Shaw JL, Haigis MC, Greka A (2021) Lipid metabolism in sickness and in health: emerging regulators of lipotoxicity. Mol Cell 81(18):3708\u20133730. https:\/\/doi.org\/10.1016\/j.molcel.2021.08.027","journal-title":"Mol Cell"},{"key":"1672_CR114","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1196\/annals.1306.025","volume":"1012","author":"MB Youdim","year":"2004","unstructured":"Youdim MB, Stephenson G, Ben SD (2004) Ironing iron out in Parkinson\u2019s disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28. Ann N Y Acad Sci 1012:306\u2013325. https:\/\/doi.org\/10.1196\/annals.1306.025","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"1672_CR115","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3390\/biom13050799","volume":"13","author":"F Zhang","year":"2023","unstructured":"Zhang F, Li X, Wei Y (2023) Selenium and selenoproteins in health. Biomolecules 13(5):799. https:\/\/doi.org\/10.3390\/biom13050799","journal-title":"Biomolecules"},{"key":"1672_CR116","doi-asserted-by":"publisher","first-page":"116512","DOI":"10.1016\/j.biopha.2024.116512","volume":"174","author":"W Zhang","year":"2024","unstructured":"Zhang W, Liu Y, Liao Y, Zhu C, Zou Z (2024) GPX4, ferroptosis, and diseases. Biomed Pharmacother 174:116512. https:\/\/doi.org\/10.1016\/j.biopha.2024.116512","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"1672_CR117","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/s41419-024-07244-x","volume":"15","author":"Y Zheng","year":"2024","unstructured":"Zheng Y, Sun J, Luo Z, Li Y, Huang Y (2024) Emerging mechanisms of lipid peroxidation in regulated cell death and its physiological implications. Cell Death Dis 15(11):859. https:\/\/doi.org\/10.1038\/s41419-024-07244-x","journal-title":"Cell Death Dis"},{"issue":"23","key":"1672_CR118","doi-asserted-by":"publisher","first-page":"13042","DOI":"10.3390\/ijms252313042","volume":"25","author":"M Zhou","year":"2024","unstructured":"Zhou M, Xu K, Ge J, Luo X, Wu M, Wang N, Zeng J (2024) Targeting ferroptosis in Parkinson\u2019s disease: mechanisms and emerging therapeutic strategies. Int J Mol Sci 25(23):13042. https:\/\/doi.org\/10.3390\/ijms252313042","journal-title":"Int J Mol Sci"},{"key":"1672_CR119","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13024-017-0218-4","volume":"12","author":"ZD Zhou","year":"2017","unstructured":"Zhou ZD, Tan EK (2017) Iron regulatory protein (IRP)-iron responsive element (IRE) signaling pathway in human neurodegenerative diseases. Mol Neurodegeneration 12:75. https:\/\/doi.org\/10.1186\/s13024-017-0218-4","journal-title":"Mol Neurodegeneration"},{"issue":"45","key":"1672_CR120","doi-asserted-by":"publisher","first-page":"19043","DOI":"10.1021\/jacs.1c08254","volume":"143","author":"O Zilka","year":"2021","unstructured":"Zilka O, Poon JF, Pratt DA (2021) Radical-trapping antioxidant activity of copper and nickel bis(thiosemicarbazone) complexes underlies their potency as inhibitors of ferroptotic cell death. J Am Chem Soc 143(45):19043\u201319057. https:\/\/doi.org\/10.1021\/jacs.1c08254","journal-title":"J Am Chem Soc"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01672-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-01672-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01672-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T09:17:20Z","timestamp":1742289440000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-01672-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":120,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["1672"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-01672-7","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,25]]},"assertion":[{"value":"22 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"All authors declared the absence of any financial or personal conflicts about this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}